|
ARHGAP11A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.870000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.608600E-01 |
| Normal-vs-Stage2 |
5.521800E-01 |
| Normal-vs-Stage3 |
5.108200E-01 |
| Normal-vs-Stage4 |
4.952600E-01 |
| Stage1-vs-Stage2 |
2.442000E-01 |
| Stage1-vs-Stage3 |
5.346000E-01 |
| Stage1-vs-Stage4 |
5.579400E-01 |
| Stage2-vs-Stage3 |
1.741040E-01 |
| Stage2-vs-Stage4 |
2.049400E-01 |
| Stage3-vs-Stage4 |
8.280600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.503400E-01 |
| Normal-vs-AfricanAmerican |
8.065200E-01 |
| Normal-vs-Asian |
9.807600E-01 |
| Caucasian-vs-AfricanAmerican |
8.592000E-01 |
| Caucasian-vs-Asian |
8.775000E-01 |
| AfricanAmerican-vs-Asian |
7.844200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.293800E-01 |
| Normal-vs-Female |
9.347800E-01 |
| Male-vs-Female |
1.404560E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.402800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.726400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.397400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.796600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.161600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.907600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.380800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.858100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.149800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.874400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.186400E-01 |
| Classical-VS-Follicular |
1.741580E-01 |
| Classical-VS-Other |
3.043200E-01 |
| Classical-VS-Normal |
4.636800E-01 |
| Tall-VS-Follicular |
3.832200E-01 |
| Tall-VS-Other |
2.658600E-01 |
| Tall-VS-Normal |
5.821200E-01 |
| Follicular-VS-Other |
5.943400E-01 |
| Follicular-VS-Normal |
7.796400E-01 |
| Other-VS-Normal |
5.370400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.182600E-01 |
| Normal-vs-N1 |
5.779600E-01 |
| N0-vs-N1 |
3.197600E-01 |
|
|
